Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of STOX1 is a novel prognostic biomarker for glioma patients

1 Jan 2021

Abstract excerpt

Abstract Storkhead box 1 (STOX1) is a winged helix transcription factor structurally and functionally related to the forkhead family of transcription factors. Recent studies have highlighted its role in the central nervous system and revealed hints in the development of glioma. However, the expression profiles of STOX1, its association with clinicopathological characteristics, and potential functions in glioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Barrier Structure and Function Studies
Share to Glioma Diagnosis and Treatment
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34722888
DOI: 10.1515/biol-2021-0119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of STOX1 is a novel prognostic biomarker for glioma patientsPMID 34722888Read ↗

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.Semantic proximity Read ↗

Prognostic value and drug sensitivity of FBXL6 in gliomaSemantic proximity Read ↗

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeuticsSemantic proximity Read ↗

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Human GliomaSemantic proximity Read ↗

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-RadiotherapySemantic proximity Read ↗

Expression profile and prognostic values of Chromobox family members in human glioblastomaSemantic proximity Read ↗

Pivotal Role of FBXW4 in Glioma Progression and Prognosis.Semantic proximity Read ↗

DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progressionSemantic proximity Read ↗

ZMYND8 as a novel diagnostic and prognostic biomarker in GliomaSemantic proximity Read ↗

SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma ProgressionSemantic proximity Read ↗

Identification and validation of SUN modification-related anti-PD-1 immunotherapy-resistance signatures to predict prognosis and immune microenvironment status in glioblastomaSemantic proximity Read ↗

Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.